4//SEC Filing
Cheng Sohanya Roshan 4
Accession 0000950170-24-007621
CIK 0001503802other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:40 PM ET
Size
5.4 KB
Accession
0000950170-24-007621
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Award
Common Stock
2024-01-24+14,167→ 221,499 total
Footnotes (2)
- [F1]Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2023 that have been earned based on the level of achievement of a certain clinical milestone, as certified by the issuer's compensation committee on January 24, 2024. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs will vest on February 28, 2024, the first anniversary of the grant date, subject to continued employment through such vesting date.
- [F2]Includes 3,246 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. Amended and Restated 2013 Employee Stock Purchase Plan.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001865796
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 7:40 PM ET
- Size
- 5.4 KB